Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
29.18 EUR | -0.36% | -0.14% | +3.88% |
May. 28 | FMC briefly burdened by research success in the fight against diabetes | DP |
May. 24 | FMC, Fresenius and Davita rise after Ozempic news | DP |
Evolution of the average Target Price on Fresenius SE & Co. KGaA
Price target over the last 5 years
History of analyst recommendation changes
Analysts' Consensus
Consensus detail
Consensus revision (last 18 months)
Analysts covering Fresenius SE & Co. KGaA
JPMORGAN | David Adlington |
DZ BANK | Sven Kürten |
JEFFERIES | James Vane-Tempest |
alphavalue | Martin Schnee |
BARCLAYS | Hassan Al-Wakeel |
BERENBERG | Victoria Lambert |
DEUTSCHE BANK RESEARCH | Falko Friedrichs |
WARBURG RESEARCH | Christian Ehmann |
UBS | Graham Doyle |
GOLDMAN SACHS | Richard Felton |
MORGAN STANLEY | Robert Davies |
CREDIT SUISSE | Christoph Gretler |
BERNSTEIN RESEARCH | Lisa Bedell Clive |
DEUTSCHE BANK | Falko Friedrichs |
NORDLB | Holger Fechner |
INDEPENDENT RESEARCH | Tobias Gottschalt |
KEPLER CHEUVREUX | Oliver Reinberg |
HSBC | Richard Latz |
EPS Revisions
- Stock Market
- Equities
- FRE Stock
- Consensus Fresenius SE & Co. KGaA